300 related articles for article (PubMed ID: 8174446)
1. Relationship between lipoprotein profile and urinary albumin excretion in type II diabetic patients with stable metabolic control.
Reverter JL; Sentí M; Rubiés-Prat J; Lucas A; Salinas I; Pizarro E; Pedro-Botet J; Romero R; Sanmartí A
Diabetes Care; 1994 Mar; 17(3):189-94. PubMed ID: 8174446
[TBL] [Abstract][Full Text] [Related]
2. Plasma cholesteryl ester transfer protein and its relationship to plasma lipoproteins and apolipoprotein A-I-containing lipoproteins in IDDM patients with microalbuminuria and clinical nephropathy.
Kahri J; Groop PH; Elliott T; Viberti G; Taskinen MR
Diabetes Care; 1994 May; 17(5):412-9. PubMed ID: 8062608
[TBL] [Abstract][Full Text] [Related]
3. Increased small dense LDL and intermediate-density lipoprotein with albuminuria in type 1 diabetes.
Sibley SD; Hokanson JE; Steffes MW; Purnell JQ; Marcovina SM; Cleary PA; Brunzell JD
Diabetes Care; 1999 Jul; 22(7):1165-70. PubMed ID: 10388983
[TBL] [Abstract][Full Text] [Related]
4. Multiple lipoprotein abnormalities in type I diabetic patients with renal disease.
Groop PH; Elliott T; Ekstrand A; Franssila-Kallunki A; Friedman R; Viberti GC; Taskinen MR
Diabetes; 1996 Jul; 45(7):974-9. PubMed ID: 8666151
[TBL] [Abstract][Full Text] [Related]
5. Albuminuria and 24-h ambulatory blood pressure in normoalbuminuric and microalbuminuric NIDDM patients. A longitudinal study.
Nielsen S; Schmitz A; Poulsen PL; Hansen KW; Mogensen CE
Diabetes Care; 1995 Nov; 18(11):1434-41. PubMed ID: 8722066
[TBL] [Abstract][Full Text] [Related]
6. Alterations in serum lipids and apolipoproteins in male type 1 (insulin-dependent) diabetic patients with microalbuminuria.
Dullaart RP; Dikkeschei LD; Doorenbos H
Diabetologia; 1989 Sep; 32(9):685-9. PubMed ID: 2507381
[TBL] [Abstract][Full Text] [Related]
7. Electronegative low density lipoprotein subform (LDL-) is increased in type 2 (non-insulin-dependent) microalbuminuric diabetic patients and is closely associated with LDL susceptibility to oxidation.
Moro E; Zambon C; Pianetti S; Cazzolato G; Pais M; Bittolo Bon G
Acta Diabetol; 1998 Oct; 35(3):161-4. PubMed ID: 9840454
[TBL] [Abstract][Full Text] [Related]
8. Lipoprotein abnormalities in well-treated type II diabetic patients.
Manzato E; Zambon A; Lapolla A; Zambon S; Braghetto L; Crepaldi G; Fedele D
Diabetes Care; 1993 Feb; 16(2):469-75. PubMed ID: 8432219
[TBL] [Abstract][Full Text] [Related]
9. High prevalence of small LDL particles in non-insulin-dependent diabetic patients with nephropathy.
Hirano T; Naito H; Kurokawa M; Ebara T; Nagano S; Adachi M; Yoshino G
Atherosclerosis; 1996 Jun; 123(1-2):57-72. PubMed ID: 8782837
[TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein(a) and cardiovascular disease in type 2 (non-insulin-dependent) diabetic patients with and without diabetic nephropathy.
Nielsen FS; Voldsgaard AI; Gall MA; Rossing P; Hommel E; Andersen P; Dyerberg J; Parving HH
Diabetologia; 1993 May; 36(5):438-44. PubMed ID: 8314449
[TBL] [Abstract][Full Text] [Related]
11. Vascular risk factors in Japanese non-insulin-dependent diabetic patients with microalbuminuria.
Kodama T; Tomiyama T; Ishizaki T; Baba T
J Diabetes Complications; 1992; 6(2):70-6. PubMed ID: 1611142
[TBL] [Abstract][Full Text] [Related]
12. Elevated serum leptin concentrations in type 2 diabetic patients with microalbuminuria and macroalbuminuria.
Fruehwald-Schultes B; Kern W; Beyer J; Forst T; Pfützner A; Peters A
Metabolism; 1999 Oct; 48(10):1290-3. PubMed ID: 10535393
[TBL] [Abstract][Full Text] [Related]
13. Lipoproteins in the DCCT/EDIC cohort: associations with diabetic nephropathy.
Jenkins AJ; Lyons TJ; Zheng D; Otvos JD; Lackland DT; McGee D; Garvey WT; Klein RL;
Kidney Int; 2003 Sep; 64(3):817-28. PubMed ID: 12911531
[TBL] [Abstract][Full Text] [Related]
14. Lipoprotein (a) and microvascular disease in type 1 (insulin-dependent) diabetes.
Winocour PH; Bhatnagar D; Ishola M; Arrol S; Durrington PN
Diabet Med; 1991 Dec; 8(10):922-7. PubMed ID: 1838043
[TBL] [Abstract][Full Text] [Related]
15. Urinary albumin excretion as a predictor of diabetic retinopathy, neuropathy, and cardiovascular disease in NIDDM.
Savage S; Estacio RO; Jeffers B; Schrier RW
Diabetes Care; 1996 Nov; 19(11):1243-8. PubMed ID: 8908388
[TBL] [Abstract][Full Text] [Related]
16. Lipoprotein alterations in hemodialysis: differences between diabetic and nondiabetic patients.
González AI; Schreier L; Elbert A; Berg G; Beresan H; López G; Wikinski R
Metabolism; 2003 Jan; 52(1):116-21. PubMed ID: 12524671
[TBL] [Abstract][Full Text] [Related]
17. Lipoprotein compositional abnormalities in type I diabetes: effect of improved glycaemic control.
Pérez A; Caixàs A; Carreras G; Mauricio D; Pou JM; Serrat J; Gómez-Gerique J; de Leiva A
Diabetes Res Clin Pract; 1997 May; 36(2):83-90. PubMed ID: 9229192
[TBL] [Abstract][Full Text] [Related]
18. Atherogenic lipoprotein changes in diabetic nephropathy.
Shoji T; Emoto M; Kawagishi T; Kimoto E; Yamada A; Tabata T; Ishimura E; Inaba M; Okuno Y; Nishizawa Y
Atherosclerosis; 2001 Jun; 156(2):425-33. PubMed ID: 11395040
[TBL] [Abstract][Full Text] [Related]
19. Hyperbetalipoproteinemia with small low-density lipoprotein, a characteristic disorder of lipoprotein in essential hypertension.
Ikeda K; Suzuki M; Ikebuchi M; Hara Y; Tsushima M; Yamamoto A; Harano Y
J Diabetes Complications; 1995; 9(4):227-9. PubMed ID: 8573733
[TBL] [Abstract][Full Text] [Related]
20. Influence of early diabetic nephropathy on very low density lipoprotein (VLDL), intermediate density lipoprotein (IDL), and low density lipoprotein (LDL) composition.
Winocour PH; Durrington PN; Bhatnagar D; Ishola M; Mackness M; Arrol S
Atherosclerosis; 1991 Jul; 89(1):49-57. PubMed ID: 1772471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
